Uzara® (Usara)

Archive
"Trade product
in Russia is not registered "
Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspsyrup
Composition:1 ml of syrup contains: as an active ingredient: root extracts dry, seminal. Lasty (Xysmalobium undulatum L. family Asclepiadaceae) (4,5 - 6,2: 1) - 7,560 mg; auxiliary substances: propylene glycol 357.600 mg, macragolglycerol hydroxystearate 3.576 mg, cola flavor 2.384 mg, glucose monohydrate 226.480 mg glucose liquid 298,000 mg, purified water 296.400 mg.
Total weight is 1192.00 mg.
Description:Transparent to opalescent solution from yellowish to brownish color with a characteristic odor.
Pharmacotherapeutic group:An antidiarrhoeal remedy of plant origin
ATX: & nbsp
  • Other antidiarrhoeal preparations
    • Pharmacodynamics:The mechanism of the anti-peristaltic action of Uzara® is based on the stimulation of the sympathetic nervous system, resulting in a weakening of the intestinal motility.
    In addition to suppressing the motility of the digestive tract, Uzara® has an antispasmodic, antisecretory, astringent and enveloping effect.
    Indications:Nonspecific acute and chronic diarrhea:
    diarrhea associated with allergic reactions;
    -Diarrhoea caused by psychoemotional factors;
    - Diarrhea caused by metabolic disorders and absorption of nutrients;
    - "diarrhea of ​​travelers", caused by a change in diet and the usual diet.
    As an aid for diarrhea of ​​infectious genesis.
    Contraindications:Hypersensitivity to the components of the drug, simultaneous treatment with cardiac glycosides, hypomagnesemia, hypokalemia, pregnancy, lactation, children under 2 years; glucose-galactose malabsorption (the drug contains glucose), impaired renal function (the drug contains propylene glycol).
    Pregnancy and lactation:In experimental studies of teratogenic, mutagenic properties, Uzara® was not identified. Until now, there have been no reports of any developmental defects in the use of the drug. Since the clinical experience of using the drug in pregnant and lactating women is very limited, the use of Uzara® during pregnancy and lactation is not shown.
    Dosing and Administration:Inside, regardless of food intake.
    Adults and children over 12 years of age: the initial dose on the first day - 25 ml of syrup once, in the following days - 5 ml 3-6 times a day before the normalization of the stool. The maximum daily dose is 30 ml.
    Children aged 6 to 12 years: the initial dose on the first day - 5-7 ml of syrup, in the following days - 3-4 ml 3-6 times a day before the normalization of the stool.
    The maximum daily dose is 24 ml.
    Children aged 2 to 6 years: 1-2 ml of syrup 3-6 times a day before the normalization of the stool.
    The maximum daily dose is 12 ml.
    The course of treatment with the drug Uzara®, the syrup should not exceed 7 days.
    Side effects:Allergic reactions.
    Interaction:At simultaneous application with preparations of calcium, saluretic or at long therapy by preparations of a cortisol occurrence of infringements of a warm rhythm is possible.
    Special instructions:If the duration of diarrhea exceeds 2 days, it is accompanied by high body temperature, and if there are impurities in the stool, you should immediately consult a doctor.
    In children, the drug should be administered under the supervision of a doctor to avoid an overdose.
    In children from 2 to 6 years of age, oral rehydration should be used as the main therapy.
    The course of treatment with the drug Uzara®, the syrup should not exceed 7 days.
    Patients with diabetes should take into account that a 1-D cap (10 ml) contains 5.25 g of glucose (about 0.4 units of bread).
    Until now, there has been no information on the adverse effects of the drug Uzara®, syrup on the performance of potentially hazardous activities requiring special attention and rapid reaction.Based on possible side effects, it is advisable to use caution when driving vehicles and working with mechanisms.
    Form release / dosage:Syrup.
    Storage conditions:Store at a temperature not exceeding 25 ° C.
    Keep out of the reach of children.
    Shelf life:5 years. Do not use the product after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-004934/07
    Date of registration:17.12.2007
    Date of cancellation:2017-09-26
    The owner of the registration certificate:SHTADA Artznajmittel AGSHTADA Artznajmittel AG Germany
    Manufacturer: & nbsp
    Information update date: & nbsp26.09.2017
    Illustrated instructions
      Instructions
      Up